SpringWorks Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
SpringWorks Therapeutics (Nasdaq: SWTX) announced CEO Saqib Islam will present at the Goldman Sachs 41st Annual Global Healthcare Conference on June 9, 2020, at 8:50 a.m. Eastern Time. The presentation will be available via a live video webcast on the company’s website, with a replay accessible for about 30 days post-conference. SpringWorks is focused on developing treatments for rare diseases and cancers, currently advancing two late-stage clinical trials and several programs targeting genetically defined cancers.
- None.
- None.
STAMFORD, Conn., June 02, 2020 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that Saqib Islam, Chief Executive Officer, will present at the Goldman Sachs 41st Annual Global Healthcare Conference on Tuesday, June 9, 2020 at 8:50 a.m. Eastern Standard Time.
A video webcast will be available live on the “Events & Presentations” page within the Investors & Media section of the company’s website at https://ir.springworkstx.com. A replay of the webcast will be available on SpringWorks’ website for approximately 30 days following the conference.
About SpringWorks Therapeutics
SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. SpringWorks has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers. SpringWorks’ strategic approach and operational excellence in clinical development have enabled it to rapidly advance its two lead product candidates into late-stage clinical trials while simultaneously entering into multiple shared-value partnerships with industry leaders to expand its portfolio. For more information, please visit www.springworkstx.com. Follow SpringWorks Therapeutics on social media: @SpringWorksTx and LinkedIn.
Contact:
Kim Diamond
Phone: 203-561-1646
Email: kdiamond@springworkstx.com
FAQ
When will SpringWorks Therapeutics present at the Goldman Sachs Healthcare Conference?
Where can I watch the live presentation of SpringWorks at the conference?
How long will the replay of the SpringWorks presentation be available?
What is the focus of SpringWorks Therapeutics?
What are the current clinical trial initiatives of SpringWorks?
